A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 07 2022
Historique:
pubmed: 2 10 2021
medline: 14 7 2022
entrez: 1 10 2021
Statut: ppublish

Résumé

The aim of this study was to compare robotic mastectomy with open classical technique outcomes in breast cancer patients. As the use of robotic nipple sparing mastectomy continues to rise, improved understanding of the surgical, oncologic, and quality of life outcomes is imperative for appropriate patient selection as well as to better understand indications, limits, advantages, and dangers. In a phase III, open label, single-center, randomized controlled trial involving 80 women with breast cancer (69) or with BRCA mutation (11), we compared the outcome of robotic and open nipple sparing mastectomy. Primary outcomes were surgical complications and quality of life using specific validated questionnaires. Secondary objective included oncologic outcomes. Robotic procedure was 1 hour and 18 minutes longer than open (P < 0.001). No differences in the number or type of complications (P = 0.11) were observed. Breast-Q scores in satisfaction with breasts, psychosocial, physical and sexual well-being were significantly higher after robotic mastectomy versus open procedure. Respect to baseline, physical and sexual well-being domains remained stable after robotic mastectomy, whereas they significantly decreased after open procedure (P < 0.02). The overall Body Image Scale questionnaire score was 20.7 ± 13.8 versus 9.9 ± 5.1 in the robotic versus open groups respectively, P < 0.0001. At median follow-up 28.6months (range 3.7-43.3), no local events were observed. Complications were similar among groups upholding the robotic technique to be safe. Quality of life was maintained after robotic mastectomy while significantly decrease after open surgery. Early follow-up confirm no premature local failure.ClinicalTrials.gov NCT03440398.

Sections du résumé

OBJECTIVE
The aim of this study was to compare robotic mastectomy with open classical technique outcomes in breast cancer patients.
SUMMARY BACKGROUND DATA
As the use of robotic nipple sparing mastectomy continues to rise, improved understanding of the surgical, oncologic, and quality of life outcomes is imperative for appropriate patient selection as well as to better understand indications, limits, advantages, and dangers.
METHODS
In a phase III, open label, single-center, randomized controlled trial involving 80 women with breast cancer (69) or with BRCA mutation (11), we compared the outcome of robotic and open nipple sparing mastectomy. Primary outcomes were surgical complications and quality of life using specific validated questionnaires. Secondary objective included oncologic outcomes.
RESULTS
Robotic procedure was 1 hour and 18 minutes longer than open (P < 0.001). No differences in the number or type of complications (P = 0.11) were observed. Breast-Q scores in satisfaction with breasts, psychosocial, physical and sexual well-being were significantly higher after robotic mastectomy versus open procedure. Respect to baseline, physical and sexual well-being domains remained stable after robotic mastectomy, whereas they significantly decreased after open procedure (P < 0.02). The overall Body Image Scale questionnaire score was 20.7 ± 13.8 versus 9.9 ± 5.1 in the robotic versus open groups respectively, P < 0.0001. At median follow-up 28.6months (range 3.7-43.3), no local events were observed.
CONCLUSIONS
Complications were similar among groups upholding the robotic technique to be safe. Quality of life was maintained after robotic mastectomy while significantly decrease after open surgery. Early follow-up confirm no premature local failure.ClinicalTrials.gov NCT03440398.

Identifiants

pubmed: 34597010
doi: 10.1097/SLA.0000000000004969
pii: 00000658-202207000-00003
doi:

Banques de données

ClinicalTrials.gov
['NCT03440398']

Types de publication

Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-19

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Headon HL, Kasem A, Mokbel K. The oncological safety of nipple-sparing mastectomy: a systematic review of the literature with a pooled analysis of 12,358 procedures. Arch Plast Surg 2016; 43:328–338.
Toesca A, Manconi A, Peradze N, et al. 1931 Preliminary report of robotic nipple-sparing mastectomy and immediate breast reconstruction with implant. Eur J Cancer 2015; 51:S309.
Toesca A, Peradze N, Galimberti V, et al. Robotic nipple-sparing mastectomy and immediate breast reconstruction with implant: first report of surgical technique. Ann Surg 2017; 266:e28–e30. Epub 2015.
Park HS, Lee J, Lee H, et al. Development of robotic mastectomy using a single-port surgical robot system. J Breast Cancer 2019; 23:107–112.
Houvenaeghel G, Bannier M, Rua S, et al. Robotic breast and reconstructive surgery: 100 procedures in 2-years for 80 patients. Surg Oncol 2019; 31:38–45.
Toesca A, Invento A, Massari G, et al. Update on the feasibility and progress on robotic breast surgery. Ann Surg Oncol 2019; 26:3046–3051.
Sarfati B, Struk S, Leymarie N, et al. Robotic prophylactic nipple-sparing mastectomy with immediate prosthetic breast reconstruction: a prospective study. Ann Surg Oncol 2018; 25:2579–2586.
Lai HW, Chen ST, Mok CW, et al. Robotic versus conventional nipple sparing mastectomy and immediate gel implant breast reconstruction in the management of breast cancer—a case control comparison study with analysis of clinical outcome, medical cost, and patient-reported cosmetic results. J Plast Reconstr Aesthet Surg 2020; 73:1514–1525.
Park HS, Lee J, Lee DW, et al. Robot-assisted nipple-sparing mastectomy with immediate breast reconstruction: an initial experience. Sci Rep 2019; 9:15669.
Toesca A, Peradze N, Manconi A, et al. Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study. Breast 2017; 31:51–56.
Lai HW, Chen ST, Lin SL, et al. Robotic nipple-sparing mastectomy and immediate breast reconstruction with gel implant: technique, preliminary results and patient-reported cosmetic outcome. Ann Surg Oncol 2019; 26:42–52.
Morigi C. Highlights from the 15th St Gallen International Breast Cancer Conference 15–18 March, 2017, Vienna: tailored treatments for patients with early breast cancer. Ecancermedicalscience 2017; 11:732.
Margenthaler JA. Robotic mastectomy-program malfunction? JAMA Surg 2020; 155:461–462.
Kopkash K, Sisco M, Poli E, et al. The modern approach to the nipple-sparing mastectomy. J Surg Oncol 2020; 122:29–35.
Selber JC. Robotic nipple-sparing mastectomy: the next step in the evolution of minimally invasive breast surgery. Ann Surg Oncol 2019; 26:10–11.
Struk S, Qassemyar Q, Leymarie N, et al. The ongoing emergence of robotics in plastic and reconstructive surgery. Ann Chir Plast Esthet 2018; 63:105–112.
Toesca A, Peradze N, Manconi A, et al. Reply to the letter to the editor “Robotic-assisted Nipple Sparing Mastectomy: A feasibility study on cadaveric models” by Sarfati B. et al. J Plast Reconstr Aesthet Surg 2017; 70:558–560.
Angarita FA, Castelo M, Englesakis M, et al. Robot-assisted nipple-sparing mastectomy: systematic review. Br J Surg 2020; 107:1580–1594.
NIH U.S. National Library of Medicine. ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT04108117 .
Lai HW, Toesca A, Sarfati B, et al. Consensus statement on robotic mastectomy- expert panel from International Endoscopic and Robotic Breast Surgery Symposium (IERBS) 2019. Ann Surg 2020; 271:1005–1012.
NIH U.S. National Library of Medicine. ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT03440398 .
Sarfati B, Struk S, Leymarie N, et al. Robotic nipple-sparing mastectomy with immediate prosthetic breast reconstruction: surgical technique. Plast Reconstr Surg 2018; 142:624–627.
Galimberti V, Morigi C, Bagnardi V, et al. Oncological outcomes of nipple-sparing mastectomy: a single-center experience of 1989 patients. Ann Surg Oncol 2018; 25:3849–3857.
Botteri E, Gentilini O, Rotmensz N, et al. Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution. Breast Cancer Res Treat 2012; 134:1221–1228.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240:205–213.
Mundy LR, Homa K, Klassen AF, et al. Breast cancer and reconstruction: normative data for interpreting the BREAST-Q. Plast Reconstr Surg 2017; 139:1046e–1055e.
Hopwood P, Fletcher I, Lee A, et al. A body image scale for use with cancer patients. Eur J Cancer 2001; 37:189–197.
Van Verschuer VM, Mureau MA, Gopie JP, et al. Patient satisfaction and nipple-areola sensitivity after bilateral prophylactic mastectomy and immediate implant breast reconstruction in a high breast cancer risk population: nipple-sparing mastectomy versus skin-sparing mastectomy. Ann Plast Surg 2016; 77:145–152.
Romanoff A, Zabor EC, Stempel M, et al. A comparison of patient-reported outcomes after nipple-sparing mastectomy and conventional mastectomy with reconstruction. Ann Surg Oncol 2018; 25:2909–2916.
Wei CH, Scott AM, Price AN, et al. Psychosocial and sexual well-being following nipple-sparing mastectomy and reconstruction. Breast J 2016; 22:10–17.
O’Dey DM, Prescher A, Pallua N. Vascular reliability of nipple-areola complex-bearing pedicles: an anatomical microdissection study. Plast Reconstr Surg 2007; 119:1167–1177.
Krajewski AC, Boughey JC, Degnim AC, et al. Expanded indications and improved outcomes for nipple-sparing mastectomy over time. Ann Surg Oncol 2015; 22:3317–3323.
Papassotiropoulos B, Giith U, Chiesa F. Prospective evaluation of residual breast tissue after skin- or nipple-sparing mastectomy: results of the SKINI-Trial. Ann Surg Oncol 2019; 26:1254–1262.
Smith BL, Tang R, Rai U, et al. Oncologic safety of nipple-sparing mastectomy in women with breast cancer. J Am Coll Surg 2017; 225:361–365.

Auteurs

Antonio Toesca (A)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Claudia Sangalli (C)

Data Management, European Institute of Oncology IRCCS, Milan, Italy.

Patrick Maisonneuve (P)

Division of Epidemiology and Biostatistics, IEO European Institute of Oncology IRCCS, Milan, Italy.

Giulia Massari (G)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Antonia Girardi (A)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Jennifer L Baker (JL)

Breast Surgery Division, Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA.

Germana Lissidini (G)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Alessandra Invento (A)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Gabriel Farante (G)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Giovanni Corso (G)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
University of Milan School of Medicine, Milan, Italy.

Mario Rietjens (M)

Division of Plastic and Reconstructive Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Nickolas Peradze (N)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Alessandra Gottardi (A)

Division of Plastic and Reconstructive Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Francesca Magnoni (F)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Luca Bottiglieri (L)

Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.

Matteo Lazzeroni (M)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Emilia Montagna (E)

Division of Medical Senology, European Institute of Oncology IRCCS, Milan, Italy.

Piergiorgio Labo (P)

Operating Theatre, European Institute of Oncology IRCCS, Milan, Italy.

Roberto Orecchia (R)

Scientific Direction, European Institute of Oncology IRCCS, Milan, Italy.

Viviana Galimberti (V)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Mattia Intra (M)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Virgilio Sacchini (V)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
University of Milan School of Medicine, Milan, Italy.
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Paolo Veronesi (P)

Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
University of Milan School of Medicine, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH